An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (Neo…

Overview of attention for article published in Trials, April 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 3,666 followers.

RT @Penta_ID: #paper on the NeoVanc #study protocol has been published as open access publication on @BioMedCentral 👉https://t.co/7qdK3C1nv…

RT @Penta_ID: #paper on the NeoVanc #study protocol has been published as open access publication on @BioMedCentral 👉https://t.co/7qdK3C1nv…

RT @Penta_ID: #paper on the NeoVanc #study protocol has been published as open access publication on @BioMedCentral 👉https://t.co/7qdK3C1nv…

RT @Penta_ID: #paper on the NeoVanc #study protocol has been published as open access publication on @BioMedCentral 👉https://t.co/7qdK3C1nv…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.